MS drug levels in breast milk under study for nursing moms
NCT ID NCT06444113
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how much of the multiple sclerosis drug ofatumumab gets into breast milk. About 24 women with relapsing MS who are breastfeeding and starting or restarting ofatumumab will provide milk samples. The goal is to measure drug concentrations, which may help guide future breastfeeding recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ofatumumab
What this could lead to
If successful, this study could help doctors give better advice to women with MS who want to breastfeed while on ofatumumab.
What could go wrong
This is a small, observational study (24 participants) that only measures drug levels in milk, not safety or long-term effects on babies. Results may not apply to all women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Womens Hospital
Brookline, Massachusetts, 02445, United States
-
Northwestern Medicine Northwestern University
Winfield, Illinois, 60190, United States
-
Novartis Investigative Site
Munich, Bavaria, 81377, Germany
-
Novartis Investigative Site
Bochum, 44791, Germany
-
Novartis Investigative Site
Hamburg, 22179, Germany
-
Novartis Investigative Site
Tübingen, 72076, Germany
-
Novartis Investigative Site
Foggia, FG, 71122, Italy
-
Novartis Investigative Site
Bialystok, 15 276, Poland
-
Novartis Investigative Site
Kielce, 25 726, Poland
-
Novartis Investigative Site
Cambridge, CB2 0QQ, United Kingdom
-
Novartis Investigative Site
London, NW1 2BU, United Kingdom
-
Novartis Investigative Site
Oxford, OX3 9DU, United Kingdom
-
Novartis Investigative Site
Salford, M6 8HD, United Kingdom
-
UC Health Neuroscience Ctr
Aurora, Colorado, 80045, United States
-
UCSF
San Francisco, California, 94115, United States